<sup>18</sup>F-FDG PET/CT for Detecting Cardiac Sarcoidosis-Reference-Cited by-同舟云学术

¹⁸F-FDG PET/CT for Detecting Cardiac Sarcoidosis

Published:2018 Issue:1 Volume:4 Page:151-154
ISSN:2189-3926
Container-title:Annals of Nuclear Cardiology
language:en
Short-container-title:

Author:

Tateishi Emi¹,Kiso Keisuke¹

Affiliation:

1. Department of Radiology, National Cerebral and Cardiovascular Center

Publisher

The Japanese Society of Nuclear Cardiology

Link

https://www.jstage.jst.go.jp/article/anc/4/1/4_18-00082/_pdf

Reference6 articles.

1. 1. The Japanese Circulation Society (JCS). Guidelines for the diagnosis and treatment of cardiac sarcoidosis (JCS2016) (Chair: Fumio Terasaki). Published on February 24, 2017 [in Japanese] (http://www.j-circ.or.jp/guideline/pdf/JCS2016_terasaki_h.pdf)

2. 2. Ishida Y, Yoshinaga K, Miyagawa M, et al. Recommendations for ¹⁸F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. Ann Nucl Med 2014; 28: 393-403.

3. 3. Chareonthaitawee P, Beanlands RS, Chen W, et al. Joint SNMMI-ASNC expert consensus document on the role of ¹⁸F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med 2017; 58: 1341-53.

4. 4. Cheng VY, Slomka PJ, Ahlen M, et al. Impact of carbohydrate restriction with and without fatty acid loading on myocardial ¹⁸F-FDG uptake during PET: A randomized controlled trial. J Nucl Cardiol 2010; 17: 286-91.

5. 5. Manabe O, Yoshinaga K, Ohira H, et al. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial ¹⁸F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol 2016; 23: 244-52.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucose metabolic rate from four-dimensional [18F]FDG PET/CT to differentiate sarcoid lesions from malignant lesions;European Radiology;2024-08-16